Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Total Non-Current Liabilities: 2018-2019

Historic Total Non-Current Liabilities for Black Diamond Therapeutics (BDTX) over the last 2 years, with Dec 2019 value amounting to $4.9 million.

  • Black Diamond Therapeutics' Total Non-Current Liabilities rose 88.85% to $4.9 million in Q4 2019 from the same period last year, while for Dec 2019 it was $4.9 million, marking a year-over-year increase of 88.85%. This contributed to the annual value of $4.9 million for FY2019, which is 88.85% up from last year.
  • Per Black Diamond Therapeutics' latest filing, its Total Non-Current Liabilities stood at $4.9 million for FY2019, which was up 88.85% from $2.6 million recorded in FY2018.
  • In the past 5 years, Black Diamond Therapeutics' Total Non-Current Liabilities ranged from a high of $4.9 million in FY2019 and a low of $2.6 million during FY2018.
  • For the 2-year period, Black Diamond Therapeutics' Total Non-Current Liabilities averaged around $3.7 million, with its median value being $3.7 million (2018).
  • Data for Black Diamond Therapeutics' Total Non-Current Liabilities shows a peak YoY spiked of 88.85% (in 2019) over the last 5 years.
  • Over the past 2 years, Black Diamond Therapeutics' Total Non-Current Liabilities (Yearly) stood at $2.6 million in 2018, then spiked by 88.85% to $4.9 million in 2019.